Lixte Biotechnology Holdings Alpha and Beta Analysis
| LIXTWDelisted Stock | USD 0.02 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Lixte Biotechnology Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Lixte Biotechnology over a specified time horizon. Remember, high Lixte Biotechnology's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Lixte Biotechnology's market risk premium analysis include:
Beta 0.47 | Alpha (0.48) | Risk 32.16 | Sharpe Ratio (0.02) | Expected Return (0.61) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Lixte |
Lixte Biotechnology Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Lixte Biotechnology market risk premium is the additional return an investor will receive from holding Lixte Biotechnology long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Lixte Biotechnology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Lixte Biotechnology's performance over market.| α | -0.48 | β | 0.47 |
Lixte Biotechnology Fundamentals Vs Peers
Comparing Lixte Biotechnology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Lixte Biotechnology's direct or indirect competition across all of the common fundamentals between Lixte Biotechnology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Lixte Biotechnology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Lixte Biotechnology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Lixte Biotechnology by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Lixte Biotechnology to competition |
| Fundamentals | Lixte Biotechnology | Peer Average |
| Return On Equity | -1.3 | -0.31 |
| Return On Asset | -0.68 | -0.14 |
| Number Of Shares Shorted | 553 | 4.71 M |
| EBITDA | (3.57 M) | 3.9 B |
| Net Income | (3.59 M) | 570.98 M |
| Cash And Equivalents | 1.08 M | 2.7 B |
| Cash Per Share | 0.10 X | 5.01 X |
Lixte Biotechnology Opportunities
Lixte Biotechnology Return and Market Media
The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Trend Reversal Possible in Lixte Biotechnology Holdings Inc. Charts Indicate - 2025 Risk Factors Capital Efficiency Focused Ideas - beatles.ru | 09/08/2025 |
2 | Is Lixte Biotechnology Holdings Inc. stock undervalued after correction - July 2025 Earnings Safe Capital Growth Tips - newser.com | 10/23/2025 |
3 | Is Lixte Biotechnology Holdings Inc. stock attractive after correction - Earnings Growth Summary Short-Term High Return Strategies - newser.com | 11/05/2025 |
4 | What technical charts say about Lixte Biotechnology Holdings Inc. Equity Warrant stock - Wall Street Watch Accurate EntryExit Alerts - newser.com | 11/11/2025 |
5 | Is Lixte Biotechnology Holdings Inc. stock resilient to inflation - Market Growth Review Consistent Profit Trading Strategies - newser.com | 11/14/2025 |
6 | Is Lixte Biotechnology Holdings Inc. stock a buy during volatile markets - Quarterly Earnings Report Technical Entry and Exit Alerts - newser.com | 11/17/2025 |
7 | Will Lixte Biotechnology Holdings Inc. stock attract ESG investors - Take Profit Growth Focused Stock Pick Reports - newser.com | 11/20/2025 |
About Lixte Biotechnology Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Lixte or other delisted stocks. Alpha measures the amount that position in Lixte Biotechnology has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Lixte Biotechnology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Lixte Biotechnology's short interest history, or implied volatility extrapolated from Lixte Biotechnology options trading.
Build Portfolio with Lixte Biotechnology
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Lixte Stock
If you are still planning to invest in Lixte Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lixte Biotechnology's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |